<DOC>
	<DOCNO>NCT01745627</DOCNO>
	<brief_summary>Evaluation safety efficacy 755nm Alex laser treatment benign pigment vascular lesion scar</brief_summary>
	<brief_title>755nm Alex Laser Treatment Pigmented Vascular Lesions Scars</brief_title>
	<detailed_description />
	<criteria>1 . Healthy male female subject 18 85 year age . 2 . Subjects Fitzpatrick skin type I VI . 3 . Subjects unwanted pigmented lesion , vascular lesion , striae and/or hypertrophic atrophic scar 4 . Subject willing consent participate study . 4.2 Exclusion Criteria 1 . Subject photographed cooperate post treatment care follow schedule 2 . Hypersensitive light exposure . 3 . Active localized systemic infection . 4 . Taking medication sunlight contraindication . 5 . History squamous cell carcinoma melanoma . 6 . History keloid scarring . 7 . Use oral isotretinoin ( AccutaneÂ® ) within 12 month initial treatment course study . Note : Skin must regain normal degree moisture prior treatment . 8 . Prior treatment laser device treatment area within 3 month 9 . History immunosuppression/immune deficiency disorder ( include HIV infection AIDS ) use immunosuppressive medication . 10 . Subjects pregnant , pregnant within last 3 month , currently breast feed plan pregnancy within study period . 11 . Subjects physician determines ineligible base standard care treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>